Search

A new γ-Fe2O3 MION ferrofluid has been developed with a salt-assisted solid-state reaction. Characterizations show that the ferrofluid is composed of maghemite nanoparticles with a mean diameter of 2.7 nm. Though the nanoparticles are ultrafine, they are well crystallized, with a saturation magnetization value of 34.7 emu g−1, making them suitable for MRI applications. In spite of the absence of any surfactant, the ferrofluid can be stable for more than 6 months. An in vitro cytotoxicity test revealed good biocompatibility of the maghemite nanoparticles, suggesting that they may be further explored for biomedical applications. NMR measurements revealed significantly reduced water proton relaxation times T1 and T2. The MR images of the nanoparticles in aqueous dispersion were investigated using a 3 T clinical MR imager. These preliminary experiments have demonstrated the potential of the as-synthesized ultrafine, cap-free maghemite MIONs in functional molecular imaging for biomedical research and clinical diagnosis.

A comprehensive totally aqueous phase synthesis of nickel-nitrilotriacetate (Ni-NTA) modified superparamagnetic Fe(3)O(4) nanoparticles is presented. The Fe(3)O(4)-NTA-Ni nanoparticles are able to perform efficient and specific purification of 6-His tagged proteins from crude cell lysates, as evidenced by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis. The average binding capacity, as demonstrated by streptopain (M(W) 42 kDa), is 0.23 mg/mg (protein/Fe(3)O(4)-NTA-Ni). Considering the high affinity and specificity of the binding between hexahistidine motif and Ni-NTA, Ni-NTA modified nanoparticles could act as a module to carry 6-His tagged proteins on the particle surface with molecular orientation control, since only the 6-His domain could be attached. These modularly designed functional nanoparticles enhance cancer cell targeting, as supported by the in vitro receptor mediated targeting assay using RGD-4C-6-His fusion peptide. The nanoparticles show no significant hemolysis for human blood and could be investigated further for their in vivo functional imaging applications.